These included 215 women with RAD51C pathogenic variants (137 were TOC or BC cases) from 125 families and 92 women with RAD51D pathogenic variants (66 were TOC or BC cases) from 60 families (Table 1). The gene discussed is RAD51D; the disease is breast cancer.